EW Stock Predictions
| Recent EW Stock Price | EW Stock Predictions | |
| $70.28 |  +11.55% |
$78.40 |
| Recent EW Analyst Ratings Breakdown, Making EW Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 10 | 9 | 9 | 10 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 17 | 18 | 18 | 16 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 1 |
| Average rating: | 2.25 | 2.32 | 2.32 | 2.32 |
For the EW stock predictions from the analysts covering Edwards Lifesciences Corp, we have collected all of the individual EW stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 25 different analysts covering EW (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since EW stock predictions may vary widely, another useful metric to consider is the median EW stock prediction, which represents the price at which half of the analysts
made EW stock predictions that were higher and half made EW stock predictions that were lower. This makes for a different take on the EW stock predictions out there, as compared to average or mean.
And that median across all the individual EW stock predictions was: $78.0 as of 2025-01-16.
The very highest of the EW stock predictions for one year price target was $90.0, while the very lowest of the EW stock predictions in the analyst group was
$68.0 (with a standard deviation of $7.053). Get the latest Zacks research report on EW — FREE
Find out: EW next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• RHI Stock Predictions
• NI Stock Predictions
• PCYG Stock Predictions
• FTAI Stock Predictions
• ETR Stock Predictions
• TSC Stock Predictions
• SNCR Stock Predictions
• FRT Stock Predictions
• LYRA Stock Predictions
|
||||||||||||
|
|
|
|
|
|
Free EW Email Alerts:
Avg. Broker Rec.
 
|
Buy (2.75 out of 4) 17th percentile
(ranked lower than approx. 83% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
